Chief Justice of India SA Bobde observed that preventing Patanjali Ayurved from using the brand name Coronil "will be terrible for the product" during the pandemic.
Since the Chinese mobile manufacturing company Vivo was dropped as IPL 2020 title sponsor, BCCI has been on the look out for sponsors.
IPL 2020: The BCCI had on August 6 confirmed that Vivo will not be the title sponsor this year.
The HC order came in a trademark infringement case filed by Chennai-based Ardura Engineering Pvt proceedings against Patanjali Ayurved
"We served notice to the hospital on Wednesday evening seeking explanation in three days. The hospital did not inform the state government nor sought permission," Chief Medical and Health Officer, Jaipur, Dr Narottam Sharma said.
The Rajasthan government has already banned the sale of Patanjali's Coronil until it gets the AYUSH ministry's nod
Patanjali Ayurveda, while presenting the Coronil medicine on June 23, claimed that it had found a cure for coronavirus infection.
Moneycontrol's Sakshi Batra does a 3 Point Analysis to understand what are the ministry's concerns and what should consumers make of it?
Baba Ramdev-led Patanjali Ayurved's Rs 250 crore debentures issue got fully subscribed within three minutes of opening on Thursday.
Though Patanjali has argued that they gave discounts on their products instead through a cash-back scheme, the anti-profiteering watchdog stated it cannot be equated with tax cut benefits that must reflect int he MRP
Baba Ramdev’s stepped into the listed space by acquiring Ruchi Soya. How should investors interpret it?
Sources said Patanjali settled Rs 4,350 crore of dues Ruchi Soya had towards financial creditors by infusing Rs 1,100 crore equity and arranging another Rs 3,250 crore via debt.
Sources also said that Patanjali has completed the process of transfer of equity and debt portions to lenders.
Patanjali also said it has got loans of Rs 1,200 crore from SBI, Rs 700 crore from Punjab National Bank, Rs 600 crore from Union Bank of India, Rs 400 crore from Syndicate Bank and Rs 300 crore from Allahabad Bank.
In September this year, Patanjali Ayurved had received approval of the National Company Law Tribunal (NCLT) to acquire Ruchi Soya, which went into an insolvency in December 2017.
The company had reported a revenue of Rs 937 crore and Rs 1,576 crore in June quarter and September quarter of 2018-19, respectively.
Patanjali’s fall from growth was as swift as its rise. Away from limelight, it appears to be resurrecting itself
Patanjali’s Ruchi Soya acquisition gives it size but also sizeable debt. The financial structure and integration are crucial to make it work
After years of superior growth, Baba Ramdev’s Patanjali Ayurved witnessed a slowdown in fiscal year 2019, as competition wised up to the opportunity in the natural products markets.
Patanjali Ayurved will source the milk directly from farmers and process it at its plants in Uttar Pradesh, Rajasthan and Maharastra.
Homegrown FMCG major almost got a walk over after rival Adani Wilmar decided to pull out from the race despite being selected the highest bidder few months back.
Patanjali, the lone player left in contention after the exit of Adani Wilmar, had last month increased its bid value by around Rs 200 crore to Rs 4,350 crore for the Madhya Pradesh-based Ruchi Soya.
Patanjali Ayurved's close to acquiring Ruchi Soya but its balance sheet already looks stretched. Going public to raise equity could solve this problem. Investors too would be happy at the prospect of owning its shares
Adani Wilmar, which emerged as the highest bidder in August last year after a long drawn battle with Patanjali, has withdrawn from the race citing delay in completion of the insolvency process.
Patanjali’s threat has been downplayed by the Street in recent years, as its performance has faltered and its competitive streak appears more subdued. Don’t write it off just yet, says the data